Share of global biopharmaceutical pipeline vs Clinical trial registrations in China
In 2025, share of global biopharmaceutical pipeline in China was 30%; clinical trial registrations was 5,215.
Change the pair
Compare different indicators
The series
Over time
China, spaced by time in 2025 . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.
Share of global biopharmaceutical pipeline
Unit: % · 1 observation
View the underlying data
| Period | Type | Value |
|---|---|---|
| 2025 | Actual | 30% |
Clinical trial registrations
Unit: count · 1 observation
View the underlying data
| Period | Type | Value |
|---|---|---|
| 2025 | Actual | 5,215 |
Shared periods
Side by side
Only one period is published for both series in China. Comparing anything else would mean comparing different years.
Provenance
Where these numbers come from
Share of global biopharmaceutical pipeline
Proportion of global biopharmaceutical research and development pipeline assets originating from a specific country or region.
2 observations in China · source organisations: State Council
Clinical trial registrations
Number of clinical trials registered on the International Clinical Trials Registry Platform.
4 observations in China · source organisations: State Council, NHSA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring